drugset / Trial / NCT03155698

Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma

NCT03155698

Unknown 50 enrolled Assiut University
NaSingle-groupOpen-labelTreatment

Summary

Vitiligo is a relatively common acquired chronic disorder of pigmentation characterized by the development of white macules on the skin due to loss of epidermal melanocytes .Affecting approximately 0.5%-2% of general population worldwide, without predilection for sex or race.

Timeline

Start
2021-08
Primary completion
2021-09
Completion
2021-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Topical

Indications